Please use this identifier to cite or link to this item: https://doi.org/10.1089/ars.2013.5295
Title: Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma
Authors: Kumar, A.P. 
Loo, S.Y.
Shin, S.W.
Tan, T.Z.
Eng, C.B.
Singh, R.
Putti, T.C.
Ong, C.W. 
Salto-Tellez, M. 
Goh, B.C.
Park, J.I.
Thiery, J.P.
Pervaiz, S.
Clement, M.V.
Issue Date: 20-May-2014
Citation: Kumar, A.P., Loo, S.Y., Shin, S.W., Tan, T.Z., Eng, C.B., Singh, R., Putti, T.C., Ong, C.W., Salto-Tellez, M., Goh, B.C., Park, J.I., Thiery, J.P., Pervaiz, S., Clement, M.V. (2014-05-20). Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. Antioxidants and Redox Signaling 20 (15) : 2326-2346. ScholarBank@NUS Repository. https://doi.org/10.1089/ars.2013.5295
Abstract: Aims: Although earlier reports highlighted a tumor suppressor role for manganese superoxide dismutase (MnSOD), recent evidence indicates increased expression in a variety of human cancers including aggressive breast carcinoma. In the present article, we hypothesized that MnSOD expression is significantly amplified in the aggressive breast carcinoma basal subtype, and targeting MnSOD could be an attractive strategy for enhancing chemosensitivity of this highly aggressive breast cancer subtype. Results: Using MDA-MB-231 and BT549 as a model of basal breast cancer cell lines, we show that knockdown of MnSOD decreased the colony-forming ability and sensitized the cells to drug-induced cell death, while drug resistance was associated with increased MnSOD expression. In an attempt to develop a clinically relevant approach to down-regulate MnSOD expression in patients with basal breast carcinoma, we employed activation of the peroxisome proliferator-activated receptor gamma (PPARγ) to repress MnSOD expression; PPARγ activation significantly reduced MnSOD expression, increased chemosensitivity, and inhibited tumor growth. Moreover, as a proof of concept for the clinical use of PPARγ agonists to decrease MnSOD expression, biopsies derived from breast cancer patients who had received synthetic PPARγ ligands as anti-diabetic therapy had significantly reduced MnSOD expression. Finally, we provide evidence to implicate peroxynitrite as the mechanism involved in the increased sensitivity to chemotherapy induced by MnSOD repression. Innovation and Conclusion: These data provide evidence to link increased MnSOD expression with the aggressive basal breast cancer, and underscore the judicious use of PPARγ ligands for specifically down-regulating MnSOD to increase the chemosensitivity of this subtype of breast carcinoma. Antioxid. Redox Signal. 20, 2326-2346. © Copyright 2014, Mary Ann Liebert, Inc. 2014.
Source Title: Antioxidants and Redox Signaling
URI: http://scholarbank.nus.edu.sg/handle/10635/116449
ISSN: 15577716
DOI: 10.1089/ars.2013.5295
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

19
checked on Nov 11, 2019

WEB OF SCIENCETM
Citations

19
checked on Nov 11, 2019

Page view(s)

109
checked on Nov 8, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.